Cannabinoids and Their Potential Role in Cancer Management | cannabisMD

Cannabinoids and Their Potential Role in Cancer Management

usage of cannabinoids and cancer Management

Image Credit: Jose Luis Carrascosa on Shutterstock

Cannabinoids are a major group of chemicals found in the cannabis plant (cannabis sativa) and are said to have anticancer effects. Cannabinoids have two main constituents that are tetrahydrocannabinol (THC) and cannabidiol (CBD). The first is responsible for cannabis’ psychoactive effects while the latter is sold in shops as an anti inflammatory. This paper will review all the information on cannabinoids antitumor properties and how they can treat different types of cancer such as prostate cancer.

Here is the full scientific article if you wish to download it.

Main Points

  • Cannabinoids may have therapeutic potential
  • Cannabinoids show promise for cancer treatment

Cannabinoids may have therapeutic potential

Cannabinoids are allowed to work in the body because of cannabinoid receptors (CB1 and CB2) located in the endocannabinoid system. The action of the medical marijuana depends on the exact dose and how long the patient is exposed. Plant and synthetic cannabinoids are starting to show a great potential as therapeutic agents and many studies from a wide range of cell lines have demonstrated that cannabinoids can treat glioma breast, prostate, endothelial, liver, and lung cancer. A lot of these studies have been quite contradictory because the mechanisms aren’t quite known yet although it is known that the extracellular signal-regulated kinase pathway is the most important location known for ceramide and lipid signalling. Overall, research suggests that there is a lot of conflicting studies around the use of the cannabinoids, synthetic and plant based, as therapeutic drugs.

Cannabinoids show promise for cancer treatment

There are plenty of problems to overcome but overall, cannabinoids show a definite promise in treating cancer. Cannabinoids and the endocannabinoid system interplay still needs to be studied in depth. This lack of depth could be filled by the knowledge in the area of normal signalling pathways used by endocannabinoids and the physiological systems used by them. Future research is needed to help clarify how this endocannabinoid signalling pathway works so that cannabinoids can be used in the treatment of cancer.

Jonathan Neilly
Jonathan Neilly
Jonathan Neilly is registered with the British Psychological Society, breaking the taboo on mental health issues is one of the driving forces in his life. His background in biomedicine gives him additional understanding of the factors that work together to influence the human condition.

Leave a Reply

Your email address will not be published. Required fields are marked *